Balance Sheet for Tetraphase Pharmaceuticals Inc. (TTPH)

$ 2.46   -0.10 (-3.91%) Volume: 228.15k 4:00 PM EDT 2-Jul-2020
After Hours:  $ 2.40   -0.06 (-2.44%) Volume: 300 7:58 PM EDT 2-Jul-2020
Statement: View:
Assets [+] in Thousands of Dollars
12/2019 12/2018 12/2017 12/2016 12/2015
Cash and Equivalents 21,239 107,776 136,411 142,086 205,912
Restrictable Cash - - - - -
Marketable Securities - - - - -
Accounts Receivable 1,503 2,274 4,653 1,789 4,151
Loans Receivable - - - - -
Other Receivables 3,000 3,000 - - -
Receivables 1,503 5,274 4,653 1,789 4,151
Inventories, Raw Materials - - - - -
Inventories, Work in Progress 115 655 - - -
Inventories, Purchased Components - - - - -
Inventories, Finished Goods 1,480 93 - - -
Inventories, Other 1,595 748 - - -
Inventories, Adjustments & Allowances - - - - -
Inventories 1,595 748 - - -
Prepaid Expenses 2,103 2,674 6,382 6,582 3,705
Current Deferred Income Taxes - - - - -
Other Current Assets - - - - -
Total Current Assets 26,493 116,472 147,446 150,457 213,768
Land and Improvements - - - - -
Buildings and Improvement 923 923 923 915 891
Machinery, Furniture and Equipment 369 4,004 3,818 3,099 2,730
Construction in Progress - - - - -
Fixed Assets, Other 4,836 - - - -
Fixed Assets, Total 6,128 4,927 4,741 4,014 3,621
Gross Fixed Assets 6,128 4,927 4,741 4,014 3,621
Accumulated Depreciation (1,194) (3,806) (3,346) (2,960) (2,678)
Net Fixed Assets 4,934 1,121 1,395 1,054 943
Intangibles - - - - -
Cost in Excess - - - - -
Non-Current Deferred Income Taxes - - - - -
Other Non-Current Assets 699 699 199 199 206
Total Non-Current Assets 9,892 6,472 1,594 1,253 1,149
Total Assets 36,385 122,944 149,040 151,710 214,917
Liabilities [+] in Thousands of Dollars
12/2019 12/2018 12/2017 12/2016 12/2015
Accounts Payable 2,429 3,210 5,306 2,555 2,857
Short Term Debt 1,547 - - - -
Notes Payable - - - - -
Accrued Expenses 5,794 11,761 12,559 7,685 6,931
Accrued Liabilities 5,794 11,761 12,559 7,685 6,931
Deferred Revenues - 6 660 1,255 909
Current Deferred Income Taxes - - - - -
Other Current Liabilities - (6) - - -
Total Current Liabilities 9,770 14,971 18,525 11,495 10,697
Long Term Debt 53,416 28,291 N/A - -
Deferred Income Tax - - - 288 165
Other Non-Current Liabilities (53,416) - 105 162 165
Minority Interest - - - - -
Capital Lease Obligations 3,448 - - - -
Preferred Securities of Subsidiary Trust - - - - -
Preferred Equity Outside Shareholders' Equity - - - - -
Total Non-Current Liabilities 3,448 28,291 105 162 165
Total Liabilities 13,218 43,262 18,630 11,657 10,862
Preferred Shareholder's Equity - - - - -
Common Shareholder's Equity 23,167 79,682 130,410 140,053 204,055
Common Par 3 3 51 37 37
Additional Paid in Capital 627,291 613,721 592,243 487,148 473,670
Cumulative Translation Adjustments - - - - -
Retained Earnings (604,127) (534,042) (461,884) (347,132) (269,652)
Treasury Stock - - - - -
Other Equity Adjustments - - - - -
Total Capitalization 76,583 107,973 130,410 140,053 204,055
Total Equity 23,167 79,682 130,410 140,053 204,055
Total Liabilities & Shareholder's Equity 36,385 122,944 149,040 151,710 214,917
Cash Flow (70,085) (72,158) (114,753) (77,480) (83,189)
Working Capital 16,723 101,501 128,921 138,962 203,071
Free Cash Flow (63,778) (64,582) (98,821) (64,159) (77,545)
Invested Capital 23,167 107,973 130,410 140,053 204,055
Shares Outstanding - Common Class Only 3,466 2,684 2,573 1,847 1,829
Preferred Shares Outstanding - - - - -
Total Ordinary Shares 3,466 2,684 2,573 1,847 1,829
Total Common Shares Outstanding 3,466 2,684 2,573 1,847 1,829
Treasury Shares - - - - -
Basic Weighted Shares Outstanding 3,067 2,626 2,179 1,835 1,763
Diluted Weighted Shares Outstanding 3,067 2,626 2,179 1,835 1,763